Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2025-12-25 @ 12:01 AM
NCT ID:
NCT02258958
Eligibility Criteria:
Patient Inclusion Criteria
* At least 18 years of age
* Either gender
* Diagnosed with resectable lung cancer or metastatic lung disease eligible to complete metastasectomy
* Undergoing one of the following surgeries: Segmentectomy, wedge resection, lobectomy, bilobectomy or pneumonectomy
* Competent to understand and sign consent documents
Patient Exclusion Criteria
* Known allergic or anaphylactic reaction to contrast dye, heparin or low molecular weight heparin (LMWH)
* Under current anticoagulation for venous thromboembolism or other medical conditions
* Known renal impairment, defined as creatinine clearance value of less than 55ml/min/m2 as calculated by the Cockroft-Gault method
* History of, or ongoing liver disease, manifested as ascites or previous peritoneal tapping for ascites
* Pregnant or planning to become pregnant
* Diagnosed or treated for VTE in the past 3 months prior to surgery
* Present or previous increase risk of haemorrhage
* History of previous HIT (heparin induced thrombocytopenia)
* Platelet count must be below 75,000
* Previously inserted Inferior Vena Cava Filter (IVC) filter.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02258958
Study Brief:
Protocol Section:
NCT02258958